Neural tube defects (NTDs) are one group of severe defects in the central nervous system, always leading to infant deaths or disabilities. Data from the National Center for Birth Defects Monitor of China showed that the incidence rate of NTDs was 4.50 per ten thousand in the year of 2011. Lots of environmental and genetic factors have been proved to be risk factor of NTDs, such as smoking, passive smoking, obesity, lack of folic acid, methylenetetrahydrofolate reductase C677T mutation and so on[@b1][@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12]. Yet, there has been less professional debate on the association between nausea and vomiting in early pregnancy (NVP) and the risk of NTDs.

NVP is a common experience in pregnancy and the meta-analytic average rate was 69.4%, but reported rates vary widely[@b13]. Meanwhile, NVP is found more often in Western countries and urban populations and rarely among Africans, Native Americans, Eskimos, and most Asian populations[@b14]. Although most women with NVP have symptoms limited to the first trimester from six weeks to 12 weeks, a small proportion of women have a prolonged course with symptoms extending until delivery. Women with severe NVP may suffer from hyperemesis gravidarum, an entity distinct from NVP, which may lead to maternal and fetal morbidity if left untreated.

Most studies have demonstrated that NVP is associated with a favorable outcome of the fetus. Weigel et al. found a strong significant association between NVP and decreased risk of miscarriage, but no consistent associations with perinatal mortality[@b15]. However, an increased risk of intrauterine growth retardation and low birth weight was associated with the women with severe NVP[@b16][@b17]. Previous studies also showed no difference in congenital abnormalities between those with and without NVP[@b11] and a lower risk of congenital heart defects in infants born to women with early onset of NVP requiring antiemetic use compared to women without nausea[@b18].

However, there has been considerable professional debate on the association between NVP and the risk of NTDs. Czeizel et al. suggested an inverse association between severe NVP and the risk of some congenital abnormalities, including NTDs[@b19]. While this association was not observed in other studies[@b20][@b21]. NVP may reduce energy intake and levels of anabolic hormones, insulin, and insulin growth factor leading to a shunting of scarce nutrients to the placenta and fetus[@b22], also including maternal level of folic acid. The evidence of public health suggests that daily folic acid supplements have a significant protective effect in preventing NTDs. It remains unknow whether the folic acid supplements intake would affect the association between NVP and NTDs. Meanwhile, the severity of nausea and vomiting was associated with the frequency of feelings of depression and adverse effects on women\'s relationships, which may have an effect on the risk of NTDs[@b23].

Therefore, we conducted a matched case-control study in China to further explore the association between NVP and NTDs risk, and the effect of folic acid supplements on the association between NVP and NTDs risk.

Methods
=======

The 1:1 matched case-control study was conducted in Shanxi Province and Shandong Province of China. We identified study subjects and collected the information from the registration cards and hospital records through the National Center for Birth Defects Monitor of China, the Maternal and Child Care Service Centers, the Family Planning Centers and the local hospitals. We excluded those without detailed home address and contact information.

Cases were the women with any infant or fetus with a diagnosis (ICD-10) of anencephaly (Q00.0), spina bifida (Q05), or encephalocele (Q01) at birth or prenatally within 2 years before the survey date (from March to December 2008). Controls were the women with live born infants, randomly selected without an apparent congenital malformation. The matching criteria were that the matched case and control were from the same region, the same hospital and childbirth in the same year in order to control the potential confounding factors by the above factors and reduce the sample size.

In the study, structured questionnaires were used for data collection. The questionnaire contained questions on maternal socio-demographic characteristics (age, education, occupation, and annual income), conditions of fetuses or infants, height and prepregnancy weight, exposure to passive smoking and pesticide, chronic diseases (anemia, diabetes, epilepsy, hyperthyroidism, tumor and hypertension), fever or cold, NVP status, intake of folic acid supplements and nutritional status in the periconceptional period. The questionnaires were administered through household-to-household survey by well-trained interviewers who had no knowledge of the main hypotheses of the study. The study protocol was reviewed and approved by the Ethics Review Committee of Public Health at Shandong University. The methods were carried out in accordance with the approved guidelines. Informed consent forms were shown to the subjects and their spouses, and signed by the subjects with the assistance of community/village doctors.

Severity of NTD was categorized by three stages: light NVP means one or none of most situation in early pregnancy with salivation or mild nausea and vomiting in early morning, which would not affect daily life; moderate NVP means that the symptoms of nausea and vomiting aggravate and occur to be not limited to the morning, which can be released after an adequate rest; severe NVP means the continuous symptoms of nausea and vomiting occur and the women need to rest in bed or be hospitalized.

Descriptive statistics were calculated for all variables; continuous variables were summarized as means and standard deviations or median and range, and categorical variables were summarized as frequencies and proportions. To determine the difference between groups, independent t test, chi-square test, or Fisher exact was used where appropriate. Body mass index (BMI) was calculated by prepregnancy weight (kg) divided by the square of height (m). Differences of categorical data between the case women and the control women were examined by conditional logistic regression models which were used to calculate odds ratios (ORs) and their 95% confidence intervals (CIs). Conditional logistic regression model was used in order to analyze the association between NVP and NTDs stratified by the variable of intake of folic acid supplements. Adjusted ORs and their 95%CIs were calculated by adjusting for the potential confounders. A two-sided P value of less than 0.05 was considered to be statistically significant. All analyses were performed using SAS software, version 9.1.3 (SAS Institute, Cary, NC, USA).

Results
=======

Totally 459 case women and 459 control women were recruited in the study. There were 194 anencephaly, 200 spina bifida and 65 encephalocele in the case group. The characteristics of the women in the case and control groups were presented in [Table 1](#t1){ref-type="table"}. The differences between the case and the control groups were statistically significant for occupation, education level, annual income, BMI, passive smoking, exposure to pesticide, intake of folic acid supplements and maternal chronic diseases (all P\<0.05) except for age.

NVP distribution in case and control groups and the OR values between NVP and NTDs risk stratified by the variable of intake of folic acid supplements were shown in [Table 2](#t2){ref-type="table"}. In the case women, 11.5% (53/459) had severe NVP and 29.0% (133/459) had moderate NVP in the first trimester. In the control women, 6.1% (28/459) had severe NVP and 24.6% (113/459) had moderate NVP in the first trimester. The OR of NTDs for the women with severe NVP was 2.403 (95%CI 1.437,4.017; *P*\<0.001) and that with moderate NVP was 1.469 (95%CI 1.063,2.031; *P* = 0.020), compared to the women with light NVP when adjusted by the potential confounders. The interaction between NVP and intake of folic acid supplements demonstrated a significantly antagonistic effect (P = 0.034). Interestingly, when stratified by intake of folic acid supplements, the ORs for severe and moderate NVP turned to 2.147 (95%CI 1.140, 4.043; *P* = 0.018) and 2.055 (95%CI 1.320, 3.199; *P* = 0.001) compared to light NVP in the stratum of non-intake of folic acid supplements, respectively. While in the stratum of intake of folic acid supplements, the ORs for severe and moderate NVP reduced to 1.851 (95%CI 0.729, 4.699) and 1.003 (95%CI 0.594, 1.694), respectively, which demonstrated no statistically significant differences compared with light NVP (P = 0.195 and P = 0.992).

The distribution and risk of NVP for the different subtypes of NTDs were shown in [Table 3](#t3){ref-type="table"} and [Table 4](#t4){ref-type="table"}. The risk of anencephaly was significantly associated with severe NVP and the OR value was 3.738 (95%CI 1.158, 12.073; *P* = 0.028) when adjusted by the potential confounders. However, no statistically significant associations were found between NVP and spina bifida/encephalocele (all *P*\>0.05). When stratified by intake of folic acid supplements, the risk of severe and moderate NVP for anencephaly rose in the group of non-intake of folic acid supplements and reduced to no statistically significant differences in the group of intake of folic acid supplements. For spina bifida, it showed no differences stratified by intake of folic acid supplements.

Discussion
==========

This study had explored the association between NVP and NTDs risk. The results showed that severe or moderate NVP had a significant association with the risk of NTDs. While this association was not found in the group with the intake of folic acid supplements.

The etiology of NVP has been well understood, but it is widely believed that physiological, psychological, genetic, and cultural components are contributing factors[@b14][@b18]. The occurrence of NVP may be of benefit in pregnancy and less likely to result in miscarriage, preterm delivery, or intrauterine growth retardation. The Maternal and Embryo Protection Hypothesis posits that pregnancy sickness results in adaptive dietary changes that reduce the exposure of the fetus and mother to dietary pathogens, toxins and parasites by reducing the intake of foods such as meat, fish and dairy products[@b24]. But the study by Weigel et al. was little direct evidence for this hypothesis[@b25]. Studies suggested that NVP was promoted by secretion of human chorionic gonadotrophin (hCG), largely on the basis of the coincidence between the onset of NVP and hCG secretion and the peaks of both at around 12 to 14 weeks in the first trimester[@b26][@b27][@b28]. Abnormal concentrations of hCG are associated with poor pregnancy outcomes. It seems that NVP and hCG are related and nutrient restriction during critical periods of embryonic development may ensure production of hCG at optimal levels to protect placental development and optimize nutrient partitioning between maternal and fetal tissues.

In our study, we found an opposite effect: a higher level of pregnancy sickness was correlated with a worse pregnancy outcome- a higher likelihood of neural tube defects. The advocates of the maternal and embryo protection hypothesis have not considered the potential costs of pregnancy sickness, in particular, reduced dietary intake. Lee et al. reported that morning sickness in pregnant women result in poor dietary diversity and reduced intakes of energy, protein, and micronutrients and, consequently, adversely affected infant outcome as well as maternal weight gain during early pregnancy[@b29]. In that case, reduced dietary intake certainly will influence or decrease the level of folic acid, which is mainly depending on food intake. It has been proved that folate deficiency could increase the risk of NTDs while intake of folic acid supplements could decrease the risk of NTDs[@b11], which is also observed from our study. The result demonstrated that severe NVP was related to the risk of NTDs in this study. Stratified by the intake of folic acid supplements, the risk of NTD by severe NVP was decreased in the group with intake of folic acid supplements. The assumption is partly proved that severe NVP may reduce the intake of nutrition and then lower the level of folic acid in the maternal body, leading to the increased risk of NTDs. These results were different from those by Czeizel et al[@b30]. The effect of NVP on NTDs risk may depend on the level of hCG and folic acid. Of course, drug treatment on NVP was not considered as a limitation in this study.

In the study, the risk of anencephaly was associated with severe NVP, while spina bifida and encephalocele were not. The NVP may have different effects on the risk of anencephaly and the other two subtypes, which means, the hypothesis was further supported that anencephaly had a different pathogenic mechanism from the other two subtypes. Anencephaly may be more sensitive than spina bifida and encephalocele to folate deficiency. Folic acid supplements are likely to improve the status of folate level in the maternal body changed by NVP.

Although some confounders have been adjusted, considering other potential confounders, both NVP and NTDs might be the results of some underlying conditions. The association between NVP and NTDs needs further study considering more potential risk factors. The results showed a strong effect of severe NVP on the risk of encephalocele. However, the actual frequency in both of the case and control women used for calculation was too small to be convincing. Further studies are needed to clarify the actual relationship between severe NVP and the risk of encephalocele.

In conclusion, this case-control study reveals that severe or moderate NVP has an association with the risk of NTDs, which was not found in the group with intake of folic acid supplements. So folic acid supplements should be recommended within three months before pregnancy or in the first trimester to use for prevention of NTDs.
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###### Characteristics of the subject women in the case and control groups

                                      Case group   Control group                                    
  ---------------------------------- ------------ --------------- ----- ------ -------------------- ---------
  Age (years)                                                                                            
  ≤24                                     75           16.3        90    19.6         1.000              
  24\~28                                 161           35.1        176   38.3   1.109(0.752,1.636)    0.603
  \>28                                   223           48.6        193   42.1   1.397(0.964,2.027)    0.078
  Occupation                                                                                             
  Manual work                            406           88.5        364   79.3   2.355(1.547,3.585)   \<0.001
  Brain work                              53           11.6        95    20.7         1.000              
  Education level                                                                                        
  ≤Middle school                         417           90.9        358   78.0   3.034(1.994,4.617)   \<0.001
  \>Middle school                         42            9.2        101   22.0         1.000              
  Annual income (RMB)                                                                                    
  Low (≤12000)                           299           65.1        189   41.2   3.245(2.356,4.47)    \<0.001
  High (\>12000)                         160           34.9        270   58.8         1.000              
  BMI\*(kg/m^2^)                                                                                         
  ≤24                                    340           74.1        370   80.6         1.000              
  \>24                                   119           25.9        89    19.4   1.484(1.075,2.048)    0.016
  Passive smoking                                                                                        
  Yes                                    177           38.6        78    17.0   3.750(2.596,5.416)   \<0.001
  No                                     282           61.4        381   83.0         1.000              
  Exposure to pesticide                                                                                  
  Yes                                     32            7.0         6    1.3    6.196(2.41,15.93)    \<0.001
  No                                     427           93.0        453   98.7         1.000              
  Intake of folic acid supplements                                                                  
  Yes                                    142           30.9        230   50.1   0.429(0.321,0.572)   \<0.001
  No                                     317           69.1        229   49.9         1.000              
  Maternal chronic diseases                                                                              
  Yes                                     30            6.5        14    3.1    2.332(1.186,4.586)    0.014
  No                                     429           93.5        445   96.9         1.000              

###### NVP distribution in case and control groups and the OR values between NVP and NTDs stratified by intake of folic acid supplements

                                                                      Case   Control                   Crude          Adjusted[\*](#t2-fn1){ref-type="fn"}                       
  ------------------------------------------------------------------ ------ --------- --------- -------------------- -------------------------------------- -------------------- -------
  NVP[\#](#t2-fn2){ref-type="fn"}                                                                                                                                                    
  Light                                                               273      318      0.002          1.000                                                       1.000             
  Moderate                                                            133      113               1.469(1.063,2.031)                  0.020                   1.626(1.117,2.366)   0.011
  Severe                                                               53      28                2.403(1.437,4.017)                 \<0.001                  1.966(1.098,3.523)   0.023
  Intake of folic acid supplements[\#](#t2-fn2){ref-type="fn"}                                                                                                                       
  Light NVP                                                            97      155      0.566          1.000                                                       1.000             
  Moderate NVP                                                         35      64                1.003(0.594,1.694)                  0.992                   0.967(0.537,1.744)   0.912
  Severe NVP                                                           10      11                1.851(0.729,4.699)                  0.195                   1.920(0.710,5.197)   0.199
  Non-intake of folic acid supplements[\#](#t2-fn2){ref-type="fn"}                                                                                                                   
  Light NVP                                                           176      163     \<0.001         1.000                                                       1.000             
  Moderate NVP                                                         98      49                2.055(1.320,3.199)                  0.001                   2.292(1.408,3.730)   0.001
  Severe NVP                                                           43      17                2.147(1.140,4.043)                  0.018                   2.103(1.058,4.180)   0.034

\*:Adjusted OR and 95%CI were calculated by adjusting for the potential confounders, including age, occupation, education, annual income, BMI, passive smoking, exposure to pesticide, chronic disease, use of folic acid supplements.

^\#^: The conditional logistic regression model was used to calculate the parameters.

###### The distribution NVP in the case and control groups for different subtypes of NTDs

                                              Anencephaly   Spina bifida   Encephalocele                                
  ------------------------------------------ ------------- -------------- --------------- ----- ----- ------- ---- ---- -----------------------------------
  NVP                                                                                                                                     
  Light                                           114           135            0.013       121   136   0.294   38   47   0.064[\*](#t3-fn1){ref-type="fn"}
  Moderate                                        58             51                        57    46            18   16                    
  Severe                                          22             8                         22    18            9    2                     
  Intake of folic acid supplements^\#^                                                                                                    
  Light NVP                                       38             65            0.590       43    66    0.742   16   24   0.625[\*](#t3-fn1){ref-type="fn"}
  Moderate NVP                                    13             33                        16    22            6    9                     
  Severe NVP                                       2             4                          7     7            1    0                     
  Non-intake of folic acid supplements^\#^                                                                                                
  Light NVP                                       76             70            0.002       78    70    0.367   22   23   0.170[\*](#t3-fn1){ref-type="fn"}
  Moderate NVP                                    45             18                        41    24            12   7                     
  Severe NVP                                       2             4                         15    11            8    2                     

\*: The *P* value was calculated by Fisher exact test.

###### Adjusted OR values between NVP and different subtypes of NTDs stratified by intake of folic acid supplements

                                                  Anencephaly       Spina bifida     Encephalocele                                   
  ------------------------------------------ --------------------- -------------- -------------------- ------- --------------------- -------
  NVP^\#^                                                                                                                                
  Light                                              1.000                               1.000                         1.000             
  Moderate                                    1.744(0.951,3.199)       0.072       1.561(0.898,2.711)   0.114   2.438(0.666,8.922)    0.093
  Severe                                      3.738(1.158,12.073)      0.028       1.313(0.615,2.805)   0.482   6.087(0.741,50.035)   0.197
  Intake of folic acid supplements^\#^                                                                                                   
  Light NVP                                          1.000                               1.000                         1.000             
  Moderate NVP                                0.842(0.330,2.146)       0.718       1.099(0.438,2.760)   0.841   0.762(0.092,6.375)    0.998
  Severe NVP                                  1.182(0.149,9.356)       0.874       1.941(0.558,6.744)   0.297           \-             \-
  Non-intake of folic acid supplements^\#^                                                                                               
  Light NVP                                          1.000                               1.000                         1.000             
  Moderate NVP                                3.148(1.340,7.398)       0.009       2.003(0.971,4.129)   0.060   3.824(0.761,19.222)   0.104
  Severe NVP                                  6.724(1.519,29.758)      0.012       1.137(0.447,2.896)   0.787   5.606(0.443,70.882)   0.183

\*:Adjusted OR and 95%CI were calculated by adjusting the potential confounders, including age, occupation, education, annual income, BMI, passive smoking, exposure to pesticide, chronic disease, and intake of folic acid supplements.

\#: The conditional logistic regression model was used to calculate the parameters.
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